• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed

    2/16/21 6:23:16 AM ET
    $CRHM
    Medical/Nursing Services
    Health Care
    Get the next $CRHM alert in real time by email
    SC 13G/A 1 tm216457d28_sc13ga.htm SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

    (Amendment No. 2)*

     

    CRH MEDICAL CORPORATION

    (Name of Issuer)

     

    Common Shares, no par value

    (Title of Class of Securities)

     

    12626F105

    (CUSIP Number)

     

    December 31, 2020

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

      x  Rule 13d-1(b)
      ¨  Rule 13d-1(c)
      ¨  Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    Continued on following pages

    Page 1 of 7 Pages

     

     

     

     

     

    CUSIP NO.  12626F105 Page 2 of 7 Pages

     

    CUSIP No.  12626F105
    (1) Names of reporting persons Nantahala Capital Management, LLC
    (2) Check the appropriate box if a member of a group (a)
    (see instructions) (b)
    (3) SEC use only  
    (4) Citizenship or place of organization MA
    Number of shares beneficially owned by each reporting person with:  
    (5) Sole voting power 0
    (6) Shared voting power 6,892,005
    (7) Sole dispositive power 0
    (8) Shared dispositive power 6,892,005
    (9) Aggregate amount beneficially owned by each reporting person 6,892,005
    (10) Check if the aggregate amount in Row (9) excludes certain shares (see instructions)  
    (11) Percent of class represented by amount in Row (9) 9.7%
    (12) Type of reporting person (see instructions) IA

     

     

     

    CUSIP NO.  12626F105 Page 3 of 7 Pages

     

    CUSIP No.  12626F105
    (1) Names of reporting persons Wilmot B. Harkey
    (2) Check the appropriate box if a member of a group (a)
    (see instructions) (b)
    (3) SEC use only  
    (4) Citizenship or place of organization USA
    Number of shares beneficially owned by each reporting person with:  
    (5) Sole voting power 0
    (6) Shared voting power 6,892,005
    (7) Sole dispositive power 0
    (8) Shared dispositive power 6,892,005
    (9) Aggregate amount beneficially owned by each reporting person 6,892,005
    (10) Check if the aggregate amount in Row (9) excludes certain shares (see instructions)  
    (11) Percent of class represented by amount in Row (9) 9.7%
    (12) Type of reporting person (see instructions) HC

     

     

     

    CUSIP NO.  12626F105 Page 4 of 7 Pages

     

    CUSIP No.  12626F105
    (1) Names of reporting persons Daniel Mack
    (2) Check the appropriate box if a member of a group (a)
    (see instructions) (b)
    (3) SEC use only  
    (4) Citizenship or place of organization USA
    Number of shares beneficially owned by each reporting person with:  
    (5) Sole voting power 0
    (6) Shared voting power 6,892,005
    (7) Sole dispositive power 0
    (8) Shared dispositive power 6,892,005
    (9) Aggregate amount beneficially owned by each reporting person 6,892,005
    (10) Check if the aggregate amount in Row (9) excludes certain shares (see instructions)  
    (11) Percent of class represented by amount in Row (9) 9.7%
    (12) Type of reporting person (see instructions) HC

     

    Item 1(a). Name of Issuer:
       
      CRH MEDICAL CORPORATION (the “Issuer”).
       
    Item 1(b). Address of the Issuer's Principal Executive Offices:
       
      Suite 619 - 999 Canada Place, World Trade Center, Vancouver, British Columbia Canada V6C 3E1
       
    Item 2(a). Name of Person Filing
       
     

    Nantahala Capital Management, LLC (“Nantahala”)

    Wilmot B. Harkey

    Daniel Mack (together the “Reporting Persons”)

       
    Item 2(b). Address of Principal Business Office or, if None, Residence:
       
     

    130 Main St. 2nd Floor

    New Canaan, CT 06840

     

    Item 2(c). Citizenship:
       
     

    Nantahala is a Massachusetts limited liability company.

    Each of Messrs. Harkey and Mack is a citizen of the United States of America.

       
    Item 2(d).

    Title of Class of Securities:

     

      Common Shares, no par value (the “Shares”).

     

     

     

     

    CUSIP NO.  12626F105 Page 5 of 7 Pages

     

    Item 2(e). CUSIP Number:
     

     

    12626F105

     

    Item 3.

    If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

     

     

    (a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

     

    (b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

     

    (c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

     

    (d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).

     

    (e) x An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

     

    (f) ¨ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).

     

    (g) x A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G).

     

    (h) ¨ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).

     

    (i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the

    Investment Company Act of 1940 (15 U.S.C. 80a-3).

     

    (j) ¨ Group, in accordance with §240.13d-1(b)(1)(ii)(J).

     

    Item 4.

     Ownership:

       
    Item 4(a).

    Amount Beneficially Owned:

     

    As of December 31, 2020, Nantahala may be deemed to be the beneficial owner of 6,892,005 Shares held by funds and separately managed accounts under its control, and as the managing members of Nantahala, each of Messrs. Harkey and Mack may be deemed to be a beneficial owner of those Shares. 

       
    Item 4(b).

    Percent of Class:

     

    As of December 31, 2020, each of the Reporting Persons may be deemed to be the beneficial owner of 9.7% of the total number of Shares outstanding (based upon information provided by the Issuer on Form 10-Q filed November 12, 2020, there were 71,413,084 Shares outstanding as of November 11, 2020).

     

     

     

     

    CUSIP NO.  12626F105 Page 6 of 7 Pages

     

    Item 4(c). Number of shares as to which such person has:
       
     

    Nantahala Capital Management, LLC

     

      (i) Sole power to vote or direct the vote 0
      (ii) Shared power to vote or to direct the vote 6,892,005
      (iii) Sole power to dispose or to direct the disposition of 0

    (iv) Shared power to dispose or to direct the disposition of 6,892,005
       
     

    Each of Messrs. Harkey and Mack:

       
      (i) Sole power to vote or direct the vote 0
      (ii) Shared power to vote or to direct the vote 6,892,005
      (iii) Sole power to dispose or to direct the disposition of 0

    (iv) Shared power to dispose or to direct the disposition of 6,892,005

     

    Item 5. Ownership of Five Percent or Less of a Class:
       
      This Item 5 is not applicable.
       
    Item 6. Ownership of More than Five Percent on Behalf of Another Person:
       
      This Item 6 is not applicable.
       
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:
       
      Each of Messrs. Harkey and Mack is filing this Schedule 13G as a control person in respect of shares beneficially owned by Nantahala, an investment adviser as described in §240.13d-1(b)(1)(ii)(E).  See Item 4(a).
       
    Item 8. Identification and Classification of Members of the Group:
       
      This Item 8 is not applicable.
       
    Item 9. Notice of Dissolution of Group:
       
      This Item 9 is not applicable.

     

     

     

    CUSIP NO.  12626F105 Page 7 of 7 Pages

     

    Item 10. Certification:
       
      By signing below each Reporting Person certifies that, to the best of such person's knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect.

     

    SIGNATURES

     

    After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete, and correct.

     

    Date:  February 16, 2021 NANTAHALA CAPITAL MANAGEMENT, LLC
       
      By: /s/ Paul E. Rehm
        Paul E. Rehm
        Chief Compliance Officer
         
      /s/ Wilmot B. Harkey
      Wilmot B. Harkey
       
      /s/ Daniel Mack
      Daniel Mack

     

     

     

    Get the next $CRHM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CRHM

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CRHM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Webb Ian disposed of $643,200 worth of Common Shares back to the company (160,800 units at $4.00) , decreasing direct ownership by 100% to 0 units (withholding tax)

    4 - CRH Medical Corp (0001461119) (Issuer)

    4/27/21 8:04:09 PM ET
    $CRHM
    Medical/Nursing Services
    Health Care

    SEC Form 4: Patrick Todd disposed of $1,981,252 worth of Common Shares back to the company (495,313 units at $4.00) , decreasing direct ownership by 100% to 0 units (tax withholding)

    4 - CRH Medical Corp (0001461119) (Issuer)

    4/27/21 8:03:22 PM ET
    $CRHM
    Medical/Nursing Services
    Health Care

    SEC Form 4 filed by Ramani Tushar M (for withholding tax)

    4 - CRH Medical Corp (0001461119) (Issuer)

    4/27/21 8:03:46 PM ET
    $CRHM
    Medical/Nursing Services
    Health Care

    $CRHM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CRH Medical downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded CRH Medical from Buy to Hold and set a new price target of $4.00

    2/9/21 9:23:25 AM ET
    $CRHM
    Medical/Nursing Services
    Health Care

    CRH Medical downgraded by RBC Capital Mkts

    RBC Capital Mkts downgraded CRH Medical from Outperform to Sector Perform

    2/9/21 7:37:20 AM ET
    $CRHM
    Medical/Nursing Services
    Health Care

    $CRHM
    SEC Filings

    View All

    SEC Form 15-12B filed by CRH Medical Corporation

    15-12B - CRH Medical Corp (0001461119) (Filer)

    5/4/21 4:30:56 PM ET
    $CRHM
    Medical/Nursing Services
    Health Care

    SEC Form S-8 POS filed by CRH Medical Corporation

    S-8 POS - CRH Medical Corp (0001461119) (Filer)

    4/28/21 5:15:59 PM ET
    $CRHM
    Medical/Nursing Services
    Health Care

    SEC Form S-8 POS filed by CRH Medical Corporation

    S-8 POS - CRH Medical Corp (0001461119) (Filer)

    4/28/21 5:14:38 PM ET
    $CRHM
    Medical/Nursing Services
    Health Care

    $CRHM
    Financials

    Live finance-specific insights

    View All

    CRH Medical Corporation Announces Customer Update

    VANCOUVER, BC, Dec. 22, 2020 /PRNewswire/ - CRH Medical Corporation ("CRH", or the "Company") (TSX: CRH) (NYSE MKT: CRHM) announces that it has received notice today that its largest customer, United Digestive ("UD"), does not intend to renew its professional services agreements pursuant to which CRH provides anesthesia services to 12 of UD's surgery centers in the Greater Atlanta Georgia market. UD represents a significant portion of CRH's revenue, and is expected to represent approximately 20% of adjusted operating shareholder EBITDA ("EBITDA") in 2021. The current professional services agreements are scheduled to expire on October 31, 2021, meaning that the non-renewal will become effe

    12/22/20 9:43:00 PM ET
    $CRHM
    Medical/Nursing Services
    Health Care

    CRH Medical Corporation Announces Completion of Majority Acquisition of FDHS Anesthesia, LLC

    VANCOUVER, BC, Dec. 14, 2020 /PRNewswire/ - CRH Medical Corporation ("CRH", or the "Company") (TSX: CRH) (NYSE MKT: CRHM), announces that it completed an accretive transaction whereby the Company has acquired a 51% interest in FDHS Anesthesia, LLC ("FDHS"), a gastroenterology anesthesia practice located in Sarasota, Florida. FDHS represents the Company's 31st acquisition, and provides anesthesia services to two ambulatory surgery centers located in Florida. The transaction was financed through a combination of CRH's credit facility and cash on hand. FDHS Transaction Highlights: Estimated annual revenue of US $3.0 million EBITDA and cash flow accretive Dr. Tushar Ramani, CEO of CRH, com

    12/14/20 8:00:00 AM ET
    $CRHM
    Medical/Nursing Services
    Health Care

    $CRHM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed

    SC 13D - CRH Medical Corp (0001461119) (Subject)

    3/8/21 10:28:37 AM ET
    $CRHM
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed

    SC 13G/A - CRH Medical Corp (0001461119) (Subject)

    2/16/21 11:51:42 AM ET
    $CRHM
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed

    SC 13G/A - CRH Medical Corp (0001461119) (Subject)

    2/16/21 6:23:16 AM ET
    $CRHM
    Medical/Nursing Services
    Health Care

    $CRHM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    WELL Health Provides an Update on its Proposed Acquisition of CRH Medical

    CRH Medical Corp.'s securityholders approved the acquisition of CRH by a subsidiary of WELL Health at the special meeting of CRH securityholders on Friday April 16, 2021. The transaction is expected to be completed on or about April 22, 2021 and represents WELL's largest acquisition to date with a total transaction value of approximately US$369.2 million. Upon closing, subscription receipts from WELL's previously announced C$302.5M equity offering will be exchanged into common shares of WELL. VANCOUVER, BC, April 19, 2021 /CNW/ - WELL Health Technologies Corp. (TSX:WELL) ("WELL" or the "Company"), a company focused on consolidating and modernizing clinical and digital assets within the heal

    4/19/21 7:00:00 AM ET
    $CRHM
    Medical/Nursing Services
    Health Care

    WELL Health Provides an Update on its Proposed Acquisition of CRH Medical

    CRH Medical Corp.'s securityholders approved the acquisition of CRH by a subsidiary of WELL Health at the special meeting of CRH securityholders on Friday April 16, 2021. The transaction is expected to be completed on or about April 22, 2021 and represents WELL's largest acquisition to date with a total transaction value of approximately US$369.2 million. Upon closing, subscription receipts from WELL's previously announced C$302.5M equity offering will be exchanged into common shares of WELL. VANCOUVER, BC, April 19, 2021 /PRNewswire/ - WELL Health Technologies Corp. (TSX:WELL) ("WELL" or the "Company"), a company focused on consolidating and modernizing clinical and digital assets within t

    4/19/21 7:00:00 AM ET
    $CRHM
    Medical/Nursing Services
    Health Care

    CRH Medical Securityholders Approve Acquisition by WELL Health

    VANCOUVER, BC, April 16, 2021 /CNW/ - CRH Medical Corporation (TSX:CRH) (NYSE:CRHM) ("CRH" or the "Company") today announced that its securityholders approved the acquisition of CRH by a subsidiary of WELL Health Technologies Corp. ("WELL Health") at the special meeting of CRH securityholders today. The special resolution approving the arrangement was approved by: (i) 97.30% of the votes cast by CRH shareholders present in person or represented by proxy at the meeting; (ii) 97.49% of the votes cast by CRH shareholders, share unitholders and optionholders voting as a single class present in person or represented by proxy at the meeting; and (iii) 97.27% of the votes cast by "minority" CRH sh

    4/16/21 4:04:00 PM ET
    $CRHM
    Medical/Nursing Services
    Health Care